Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 77-36-1
Drug Levels and Effects
Summary of Use during Lactation
Although amounts of chlorthalidone in milk are not great, its slow clearance may lead to accumulation in the infant, especially while nursing a newborn or preterm infant. It may also suppress lactation. An alternate drug may be preferred.
Drug Levels
Maternal Levels. In 7 women taking 50 mg of oral chlorthalidone daily prior to and after delivery, milk levels 3 days after delivery (collection times unspecified) ranged from 90 to 860 mcg/L. The authors estimated that the infant would receive about 180 mcg daily of chlorthalidone from milk at this maternal dosage.[1] This would amount to about 6% of the maternal weight-adjusted dosage.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Chlorthalidone has been used successfully to suppress lactation by giving 200 mg orally right after delivery, followed by 100 mg daily for 3 days in conjunction with fluid restriction and breast binding.[2] However, a comparative study found no difference between chlorthalidone 200 mg daily for 7.6 days and placebo in milk leakage and breast engorgement and pain.[3] The added contribution of the diuretic to fluid restriction and breast binding, which are effective in suppressing lactation, has not been studied. There are no data on the effects of diuretics on established, ongoing lactation.
Alternate Drugs to Consider
References
- 1.
- Mulley BA, Parr GD, Pau WK, et al. Placental transfer of chlorthalidone and its elimination in maternal milk. Eur J Clin Pharmacol. 1978;13:129–31. [PubMed: 658109]
- 2.
- Reiher KH. Zentralbl Gynakol. 1963;85:188–90. [Suppression of lactation by stimulation of diuresis] [PubMed: 13973786]
- 3.
- Vercruysse J. Brux Med. 1966;46:1258–66. [Inhibition of lactation. Comparative study of an estro-androgen and of a diuretic] [PubMed: 6011090]
Substance Identification
Substance Name
Chlorthalidone
CAS Registry Number
77-36-1
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Metolazone.[Drugs and Lactation Database (...]Review Metolazone.. Drugs and Lactation Database (LactMed®). 2006
- Review Tolazamide.[Drugs and Lactation Database (...]Review Tolazamide.. Drugs and Lactation Database (LactMed®). 2006
- Review Quazepam.[Drugs and Lactation Database (...]Review Quazepam.. Drugs and Lactation Database (LactMed®). 2006
- Review Methyclothiazide.[Drugs and Lactation Database (...]Review Methyclothiazide.. Drugs and Lactation Database (LactMed®). 2006
- Review Lormetazepam.[Drugs and Lactation Database (...]Review Lormetazepam.. Drugs and Lactation Database (LactMed®). 2006
- Chlorthalidone - Drugs and Lactation Database (LactMed®)Chlorthalidone - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...